Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use-Reference-Cited by-同舟云学术

Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use

Published:2015-05-20 Issue:10 Volume:35 Page:1707-1716
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Takahashi Nobunori,Fujibayashi Takayoshi,Kida Daihei,Hirano Yuji,Kato Takefumi,Kato Daizo,Saito Kiwamu,Kaneko Atsushi,Yabe Yuichiro,Takagi Hideki,Oguchi Takeshi,Miyake Hiroyuki,Watanabe Tsuyoshi,Hayashi Masatoshi,Kanayama Yasuhide,Funahashi Koji,Hanabayashi Masahiro,Hirabara Shinya,Asai Shuji,Takemoto Toki,Terabe Kenya,Asai Nobuyuki,Yoshioka Yutaka,Ishiguro Naoki,Kojima Toshihisa

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-015-3283-4.pdf

Reference37 articles.

1. Westhovens R, Robles M, Ximenes AC, Nayiager S, Wollenhaupt J, Durez P et al (2009) Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors. Ann Rheum Dis 68:1870–1877

2. Takahashi N, Kojima T, Terabe K, Kaneko A, Kida D, Hirano Y et al (2013) Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients. Mod Rheumatol 23:904–912

3. Takahashi N, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T et al (2014) Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity. Clin Rheumatol 33:39–47

4. Kremer JM, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Westhovens R et al (2011) Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial. Ann Rheum Dis 70:1826–1830

5. Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C et al (2006) Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med 144:865–876

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of frailty with RA-ILD and poor control of disease activity in patients with rheumatoid arthritis: A multi-center retrospective observational study;Journal of Orthopaedic Science;2023-12

2. Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus;Clinical Rheumatology;2022-08-08

3. Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study;Modern Rheumatology;2022-04-07

4. Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis;Modern Rheumatology;2022-03-15

5. Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis;RMD Open;2021-01